M Ventures (Merck)

Cambridge, Massachusetts
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Founded:2009
Firm Location:Cambridge, Massachusetts • Amsterdam, Netherlands • Germany • Netherlands
M Ventures (Merck) Team
Photo of Olga Danilchanka, Partner at M Ventures (Merck)
Olga Danilchanka
Sweet spot: $17.5M
Range: $15.0M - $20.0M
Investors in Cambridge (MA)
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists)
Photo of Peter Dudek, Managing Partner at M Ventures (Merck)
Peter Dudek
M Ventures (Merck)·Managing Partner
Sweet spot: $17.5M
Range: $15.0M - $20.0M
Investors in Cambridge (MA)
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists)
Photo of Christian Patze, Investor at M Ventures (Merck)
Christian Patze
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Germany
Photo of Jason Ruth, Partner at M Ventures (Merck)
Jason Ruth
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United States, Investors in Boston / New England, Investors in Boston (MA), Investors in Cambridge (MA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists)
Photo of Anique ter Braake, Associate at M Ventures (Merck)
Anique ter Braake
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Netherlands
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A)
Photo of Cheryl Zimberlin, Investor at M Ventures (Merck)
Cheryl Zimberlin
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Amsterdam (Netherlands)